TTOO
- T2 Biosystems, Inc.
()
Overview
Company Summary
T2 Biosystems, Inc. is a company that specializes in the development and commercialization of innovative diagnostic products for critical unmet needs in healthcare. Their primary focus lies in the field of diagnostics for severe infections and diseases.
T2 Biosystems has developed a proprietary technology platform called T2 Magnetic Resonance (T2MR). This technology enables rapid and accurate detection of pathogens, such as bacteria, viruses, and fungi directly from patient blood samples, without the need for traditional culture-based methods.
One of the company's key products is the T2Dx Instrument, which is an FDA-cleared diagnostic instrument. It utilizes the T2MR technology to identify infections quickly, helping healthcare professionals make more informed treatment decisions. The T2Dx Instrument is designed to be user-friendly and is capable of running multiple tests simultaneously.
T2 Biosystems primarily targets life-threatening infections, including bloodstream infections, which are a major cause of morbidity and mortality in hospitals worldwide. Their diagnostic solutions aim to provide timely and accurate results, allowing for early detection, appropriate treatment, and the potential to improve patient outcomes.
In addition to their focus on infectious diseases, T2 Biosystems is also investing in expanding their product portfolio to include tests for additional medical conditions. They are actively engaged in research and development efforts to bring new diagnostic solutions to market and improve the healthcare landscape.
Overall, T2 Biosystems is dedicated to providing transformative diagnostic technologies that enhance patient care by enabling faster and more accurate diagnoses of severe infections and diseases.